Astrazeneca (AZN)

 

AZN Share PerformanceMore

52 week high5,505 05/08/16
52 week low3,680 24/06/16
52 week change 907 (21.47%)
4 week volume47,237,312 31/08/16

Latest NewsMore

Director/PDMR Shareholding

RNS Number: 8429K AstraZeneca PLC 26 September 2016 26 September 2016 16:00 Transaction by Person Discharging Managerial Responsibilities Disclosure Rule DTR 3.1.4 On 26 September 2016, the interest of Sean Bohen, a person discharging managerial responsibilities, in the ordinary shares of AstraZeneca PLC changed as detailed below. The change in interest rela...

Shell's 70-year dividend record at risk

Shell hasn't cut the dividend since WW2, but these fund managers think it will have to. Lee Wild finds out why they've sol...

Director Declaration

RNS Number: 5617K AstraZeneca PLC 22 September 2016 22 September 2016 11.00 New external board appointment Listing Rule LR 9.6.14 R (2) Ann Cairns, a Non-Executive Director of AstraZeneca PLC, is expected to join the Board of Directors of Intercontinental Exchange, Inc., a company listed on the New York Stock Exchange, effective from 2017. About AstraZ...

Broker Forecast - Societe Generale issues a broker note on AstraZeneca PLC

Societe Generale today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and set its price target at 7000...

Broker Forecast - Exane BNP Paribas issues a broker note on AstraZeneca PLC

Exane BNP Paribas today downgrades its investment rating on AstraZeneca PLC (LON:AZN) to neutral (from outperform...

Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC

Liberum Capital today reaffirms its hold investment rating on AstraZeneca PLC (LON:AZN) and set its price target at 520...

Should you pile into this healthcare stock after today’s update?

Life science research tool supplier Abcam (LSE:ABC) has released an upbeat set of full year results. They show that the com...

Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC

Jefferies International today upgrades its investment rating on AstraZeneca PLC (LON:AZN) to buy (from hold) and raise...

Latest discussion posts More

  • Bought this morning

    Reinvested some of the cash from ARM shares in AZN because of generally progressive yield currently around 3.7%, forecast 4.2%, also improved SP performance over the last year. ...
    21-Sep-2016
    Rhigos
  • FT comment

    "AstraZeneca dodged a London market sell-off on Monday on optimism that potential blockbusters in its cancer drugs pipeline can revive earnings growth. Jefferies, ...
    14-Sep-2016
    nk1999
  • Jefferies

    From ADVFN: "Jefferies upgraded AstraZeneca to 'buy' from 'hold' and lifted the price target to 5,800p from 5,400p saying it sees a much higher probability of success and ...
    12-Sep-2016
    nk1999

Users' HoldingsMore

Users who hold Astrazeneca also hold..
GLAXOSMITHKLINE49%
VODAFONE GRP.39%
BP36%
NATIONAL GRID35%
RDS 'B'34%

Codes & Symbols

ISINGB0009895292
SymbolsAZN, LSE:AZN, AZN.L, AZN:LN, LON:AZN, XLON:AZN